We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+21.22%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.34B
AUM Growth
+$272M
Cap. Flow
-$55M
Cap. Flow %
-2.35%
Top 10 Hldgs %
19.41%
Holding
258
New
26
Increased
51
Reduced
147
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 28.71%
2 Technology 22.09%
3 Industrials 19.62%
4 Consumer Discretionary 9.59%
5 Financials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIVN icon
26
LivaNova
LIVN
$4.43B
$25.3M 1.08%
488,436
-134,055
-22% -$6.49M
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
$25.2M 1.08%
1,068,661
+84,886
+9% +$1.51M
HRI icon
28
Herc Holdings
HRI
$4.99B
$24.8M 1.06%
166,835
-20,954
-11% -$2.56M
PLMR icon
29
Palomar
PLMR
$3.59B
$24.7M 1.06%
445,331
-6,207
-1% -$347K
AIR icon
30
AAR Corp
AIR
$5.38B
$24.6M 1.05%
394,734
-6,706
-2% -$431K
ITCI
31
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$24.6M 1.05%
343,820
-37,920
-10% -$2.18M
RMBS icon
32
Rambus
RMBS
$11B
$24.5M 1.05%
358,693
-5,586
-2% -$348K
PDFS icon
33
PDF Solutions
PDFS
$2.14B
$24.3M 1.04%
754,856
+193,936
+35% +$5.88M
ONTO icon
34
Onto Innovation
ONTO
$13.9B
$23.5M 1.01%
153,599
+71,329
+87% +$9.6M
FORM icon
35
FormFactor
FORM
$8.23B
$23.4M 1%
561,893
+79,982
+17% +$2.93M
CRDO icon
36
Credo Technology Group
CRDO
$37.8B
$23.2M 0.99%
1,190,011
+86,727
+8% +$1.47M
RARE icon
37
Ultragenyx Pharmaceutical
RARE
$2.88B
$23.1M 0.99%
482,138
-9,551
-2% -$370K
ONT
38
Onterris Inc
ONT
$756M
$22.8M 0.98%
710,461
-66,760
-9% -$1.92M
PRVA icon
39
Privia Health
PRVA
$3.39B
$22.7M 0.97%
983,506
+74,648
+8% +$1.67M
SMPL icon
40
Simply Good Foods
SMPL
$980M
$22.4M 0.96%
566,333
-531,269
-48% -$19.8M
INDI icon
41
indie Semiconductor
INDI
$809M
$22M 0.94%
2,709,403
-59,179
-2% -$386K
BWIN
42
Baldwin Insurance Group
BWIN
$2.66B
$21.3M 0.91%
888,217
-45,869
-5% -$975K
BJRI icon
43
BJ's Restaurants
BJRI
$1.42B
$21.1M 0.9%
586,412
-7,714
-1% -$219K
JACK icon
44
Jack in the Box
JACK
$286M
$20.5M 0.88%
251,618
+6,806
+3% +$482K
COLL icon
45
Collegium Pharmaceutical
COLL
$1.17B
$20.5M 0.88%
666,096
-24,391
-4% -$611K
SVV icon
46
Savers
SVV
$1.53B
$20.3M 0.87%
1,166,476
+295,799
+34% +$4.48M
RPD icon
47
Rapid7
RPD
$815M
$19.8M 0.85%
346,024
-4,897
-1% -$256K
HLI icon
48
Houlihan Lokey
HLI
$9.67B
$19.7M 0.84%
164,212
-2,757
-2% -$299K
FA icon
49
First Advantage
FA
$3.83B
$19.6M 0.84%
1,183,116
+247,776
+26% +$3.62M
AX icon
50
Axos Financial
AX
$5.66B
$19.5M 0.83%
356,525
+180,129
+102% +$7.52M

Similar funds

Emerald Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Emerald Advisers held 258 positions worth $2.34B, up 13% from $2.06B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q4 2023 filing shows 26 new, 51 increased, 147 reduced and 16 closed positions. Its largest new stake was Q2 Holdings: 391,834 shares worth $17M. The largest sale was Simply Good Foods, an estimated $19.8M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • Emerald Advisers's largest Q4 2023 buy was Q2 Holdings: 391,834 shares worth $17M.
  • Emerald Advisers added most to Onto Innovation in Q4 2023, an estimated $9.6M increase.
  • Emerald Advisers's biggest Q4 2023 reduction was Simply Good Foods, cutting an estimated $19.8M.
  • Emerald Advisers fully exited MODEL N, INC. in Q4 2023, selling an estimated $15M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.34B portfolio in Q4 2023.
  • Emerald Advisers opened 26 new positions and closed 16 in Q4 2023.
  • Emerald Advisers's portfolio value rose 13% quarter-over-quarter to $2.34B.

Based on Emerald Advisers's 13F filing for Q4 2023, filed 5 Feb 2024.